Oligospermia (Low Sperm Count): Options to Conceive

Oligospermia is a sperm concentration below 16 million per millilitre (WHO 2021 reference value). It is diagnosed on semen analysis and graded as mild (10-15M/mL), moderate (5-10M/mL), severe (<5M/mL), or cryptozoospermia (<100,000/mL). The most common treatable cause is varicocele. Treatment depends on severity and ranges from lifestyle change and varicocele repair for mild cases, to IUI for moderate cases with adequate motile sperm after washing, to IVF with ICSI for severe oligospermia. Conception is achievable for most men with oligospermia when the appropriate treatment pathway is followed.

Key Takeaways

• Oligospermia means a sperm concentration below 16 million per millilitre, as defined by the WHO 2021 (6th edition) reference values. Below 5 million/mL is severe oligospermia. Below approximately 100,000/mL is called cryptozoospermia.
• Varicocele is the single most common identifiable and treatable cause, present in 35-40% of men with oligospermia.
• Mild to moderate oligospermia with a normal female partner can often be treated with varicocele repair, lifestyle optimisation, and IUI. Severe oligospermia typically requires IVF with ICSI.
• Sperm count is not the only variable that determines fertility. Motility, morphology, and DNA fragmentation all matter. A man with 8 million/mL but 65% motility may have better reproductive potential than a man with 20 million/mL and 10% motility.
• Oligospermia is not permanent in most cases. Identifying and treating the underlying cause, especially varicocele, significantly improves sperm count in the majority of operated men.

Key Terms Defined

Oligospermia: A sperm concentration below 16 million per millilitre of semen, as defined by the World Health Organization’s 5th percentile reference value (2021, 6th edition). Also called low sperm count. A single below-normal result is not diagnostic; two separate semen analyses at least 2-3 months apart are required to confirm oligospermia, because sperm count varies significantly between ejaculates.

Total sperm count vs. sperm concentration: Concentration is the number of sperm per millilitre. Total count is concentration multiplied by semen volume. The WHO 2021 lower reference limit for total sperm count per ejaculate is 39 million. A man with normal volume but low concentration, or normal concentration but low volume, may meet one threshold and fail the other. Both are reported on a standard semen analysis.

Total motile count (TMC): Concentration × volume × percentage of motile sperm = total motile sperm in the ejaculate. TMC is the most clinically useful single number for predicting natural conception potential and determining which treatment (IUI, IVF, ICSI) is appropriate. A TMC below 5 million generally indicates IVF/ICSI rather than IUI.

Cryptozoospermia: Sperm concentration below approximately 100,000/mL. Sperm may be found on high-speed centrifugation of the pellet even when the initial analysis shows zero. Cryptozoospermia sits between severe oligospermia and azoospermia in severity and is managed similarly to azoospermia in treatment planning.

Understanding Your Semen Analysis: What the Numbers Mean?

A semen analysis measures multiple parameters simultaneously. Oligospermia refers specifically to sperm count (concentration), but a low count rarely exists in isolation: it is typically accompanied by some reduction in motility or morphology as well.

WHO 2021 (6th edition) lower reference limits:

A result below any of these thresholds is in the lowest 5% of the fertile male reference population: it does not mean infertile, but it does mean the result is unusual enough to warrant clinical evaluation.

Severity grading for sperm concentration:

Causes of Low Sperm Count

Most oligospermia has an identifiable cause. Finding and addressing the cause is the most important step before deciding on a treatment pathway, because treating the cause may restore or substantially improve sperm count.

Varicocele

Varicocele, the abnormal dilation of the testicular veins (equivalent to varicose veins of the scrotum), is the most common identifiable and reversible cause of oligospermia. It is found in 35-40% of men presenting with primary infertility and in up to 80% of men with secondary infertility (inability to conceive after a previous successful pregnancy). Varicocele impairs sperm production by raising testicular temperature and reducing testicular oxygenation, leading to progressive decline in count, motility, and DNA integrity over years. It is also the most important cause to identify early because varicocele surgery is effective and prevents further deterioration.

Hormonal Imbalances

The hypothalamic-pituitary-gonadal (HPG) axis controls testosterone production and spermatogenesis. Disruption at any level causes oligospermia. Causes include hypogonadotropic hypogonadism (HH: low FSH and LH drive, treatable with gonadotropin therapy), hyperprolactinaemia (elevated prolactin suppresses GnRH), thyroid disorders, and adrenal dysfunction. Low testosterone is the hormonal finding most frequently associated with oligospermia in clinical practice.

Genetic Factors

Klinefelter syndrome (47,XXY) causes testicular failure and is the most common genetic cause of severe oligospermia or azoospermia, affecting approximately 1 in 600 men. Y-chromosome microdeletions in the AZFc region are associated with severe oligospermia (AZFa/AZFb deletions typically cause azoospermia). Cystic fibrosis (CFTR mutations) causes congenital bilateral absence of the vas deferens, usually presenting as azoospermia but occasionally as severe oligospermia.

Lifestyle Factors

Smoking, heavy alcohol use, anabolic steroid use, obesity, heat exposure to the scrotum, recreational drug use (cannabis, cocaine), and chronic psychological stress all suppress sperm production. These factors are additive: a man who smokes, is obese, and uses cannabis regularly has a meaningfully lower sperm count than a non-smoking man of healthy weight. These factors are also the most modifiable: addressing them does not require medical intervention and shows effect within 3 months (one spermatogenesis cycle). For a full guide see our nutrition and lifestyle programme for sperm health.

Testicular Causes

Undescended testis (cryptorchidism), even when surgically corrected in childhood, carries a persistent risk of reduced spermatogenesis due to thermal and ischaemic damage during the undescended period. Past orchitis (testicular infection or inflammation), including mumps orchitis after puberty, causes direct tubular damage and is a common historical cause of oligospermia in men who had severe mumps in their teens or twenties. Small testis volume (below 12 mL by orchidometry) is an independent predictor of spermatogenic impairment.

Genital Tract Infections

Bacterial infections of the prostate, epididymis, or seminal vesicles cause oligospermia through direct tubular obstruction, systemic inflammation, and elevated reactive oxygen species in the seminal plasma. Semen infections are diagnosed by semen culture and leukocytospermia analysis and are treated with targeted antibiotics. Post-infective scarring may cause persistent oligospermia even after the infection resolves.

Medications and Chemotherapy

Anabolic steroids are the most common medication cause of oligospermia: exogenous testosterone suppresses LH and FSH, switching off spermatogenesis within weeks. Many men present with severe oligospermia or azoospermia after gym steroid use and recover gradually after stopping, typically over 3-18 months. Alkylating chemotherapy agents (cyclophosphamide, busulfan) cause DNA damage in spermatogonia and may cause permanent oligospermia depending on dose. Sulfasalazine, calcium channel blockers, and some antidepressants also impair semen parameters.

Ejaculatory and Ductal Causes

Retrograde ejaculation (semen entering the bladder instead of the urethra) produces a low-volume ejaculate with oligospermia or apparent azoospermia on semen analysis. Post-ejaculate urine analysis reveals sperm. Ejaculatory duct obstruction produces similar findings with a characteristically low-volume, acidic ejaculate. Both are identifiable on clinical history and investigation.

Idiopathic Oligospermia

In 30-40% of men with oligospermia, no identifiable cause is found despite full investigation. This is called idiopathic oligospermia. Treatment is empirical (antioxidants, gonadotropin supplementation in some cases) while proceeding to IUI or IVF/ICSI based on severity.

How Oligospermia Is Diagnosed?

A structured diagnostic workup does two things: confirms the diagnosis (two semen analyses) and identifies the cause (clinical, hormonal, imaging, genetic). The cause determines the treatment.

Step 1: Two Semen Analyses

A single semen analysis is never sufficient to diagnose oligospermia. Sperm count varies substantially between ejaculates due to illness, abstinence period, stress, and seasonal variation. The standard protocol requires two semen analyses at least 2-3 months apart (one spermatogenesis cycle), with 2-5 days abstinence before each. Both must show low count for oligospermia to be confirmed.

If the second sample is borderline or contradictory, a third analysis is appropriate. The best result of the series (not the average) is used for clinical decision-making in most protocols.

Step 2: Advanced Sperm Assessment

Beyond the standard semen analysis, advanced sperm morphology assessment using Kruger strict criteria provides detailed information about the proportion of normally shaped sperm. Sperm DNA fragmentation testing is recommended in men with oligospermia who are planning IVF or who have failed IUI cycles, as elevated DNA fragmentation independently impairs IVF outcomes. Semen vitality (eosin test) and the hypo-osmotic swelling test (HOS) are additional sperm function tests used in complex cases.

Step 3: Hormone Panel

FSH, LH, total testosterone, and prolactin are the minimum hormone tests. Elevated FSH with low count indicates primary testicular failure (spermatogenic damage). Normal or low FSH with low count and low testosterone indicates secondary (hypogonadotropic) failure, which is more treatable. Thyroid function tests and morning cortisol are added when clinically indicated.

Step 4: Scrotal Ultrasound

Scrotal ultrasound identifies varicocele (the most common treatable cause), testicular volume, epididymal abnormalities, and testicular lesions. A varicocele grade 2 or above on ultrasound in a man with oligospermia is an indication for surgical repair before ART in most guidelines.

Step 5: Genetics

Karyotype (47,XXY and other chromosomal abnormalities) and Y-chromosome microdeletion testing are recommended in men with sperm count below 5 million/mL. These results do not change the treatment (ICSI is used regardless) but determine the genetic information the couple needs before proceeding with IVF, as some Y-microdeletion patterns are transmitted to male offspring. CFTR testing is added when ejaculate volume is low or absent.

Treatment Options for Oligospermia

The treatment pathway is determined by the cause (if identified), the severity of the count reduction, and the partner’s fertility status. These factors together determine whether natural conception is realistic, which ART treatment has the best success rate, and what can be done to improve the count before ART.

1. Treat the Underlying Cause First

This is the most important principle, and the one most often skipped in favour of jumping directly to IVF. When the cause is treatable, treating it is always the first step, because it may restore the count to the point where less invasive treatment or natural conception becomes viable.

Varicocele repair: Varicocele surgery (microsurgical subinguinal varicocelectomy) improves sperm count in the majority of men with clinical varicocele, with mean count increases of 10-20 million/mL reported in large meta-analyses. Multiple men with severe oligospermia before varicocele surgery have achieved natural conception 3-6 months post-operatively. Even when the count does not recover to normal, varicocele repair before IVF improves IVF outcomes compared to proceeding directly with an untreated varicocele.

Hypogonadotropic hypogonadism: Gonadotropin therapy (hCG + FSH injections) stimulates the pituitary-testicular axis and produces sperm in men with secondary hypogonadism. This is one of the few causes where the count can improve from zero or near-zero to a level adequate for natural conception or IUI. It requires 6-18 months of treatment. FSH/LH levels must be measured first: giving gonadotropins to a man with primary (not secondary) failure is ineffective.

Infection: Targeted antibiotic treatment for seminal tract infections, guided by semen culture results, resolves oligospermia when infection is the primary cause.

Medication withdrawal: Stopping anabolic steroids typically results in gradual recovery of spermatogenesis over 3-18 months. Clomiphene citrate or hCG is sometimes used to accelerate HPG axis recovery.

Lifestyle optimisation: Smoking cessation, weight normalisation, alcohol reduction, heat avoidance, and targeted antioxidant supplementation (CoQ10 300-400 mg, Vitamin C + E, N-acetylcysteine 600 mg, selenium 100-200 mcg, zinc 15-30 mg, folate 400 mcg) typically improve sperm count by 15-40% in men with oligospermia attributable to oxidative stress. Effects are measurable at 3 months and continue for up to 6 months. See the nutrition programme for sperm health for clinical support.

Acupuncture: For men with idiopathic oligospermia, acupuncture for male infertility is an evidence-supported adjunct therapy that may improve semen parameters and reduce oxidative stress.

2. Timed Intercourse with Follicular Tracking

For men with mild oligospermia (10-15 million/mL) and adequate motility, follicular tracking and timed intercourse maximises the probability of natural conception by timing intercourse to the female partner’s ovulation window. This approach is used when the female partner’s fertility workup is normal and when the couple wants to attempt natural conception for 3-6 months while lifestyle optimisation is underway.

3. IUI (Intrauterine Insemination)

IUI treatment is appropriate for men with mild to moderate oligospermia when the total motile count after sperm washing reaches the threshold required for IUI (typically 5-10 million total motile sperm, clinic-dependent). In IUI, the prepared sperm sample is placed directly inside the uterus, bypassing the cervical barrier and reducing the distance sperm must travel. It does not assist fertilisation: the sperm must still reach and fertilise the egg unaided.

When IUI is appropriate: Mild oligospermia (10-15M/mL) with adequate motility. Moderate oligospermia (5-10M/mL) when TMC after wash exceeds threshold. Female partner under 35 with normal fallopian tubes and ovarian reserve. Usually combined with ovulation induction to increase the number of eggs available.

When IUI is not appropriate: Severe oligospermia (TMC after wash below 5 million). Blocked tubes or significant female factor. Female partner over 38 (success rates per cycle are too low to justify the cycles required).

Success rates: IUI success is approximately 10-15% per cycle in well-selected couples. Typically 3-4 cycles are recommended before escalating to IVF if unsuccessful.

4. IVF with ICSI

IVF treatment with ICSI is the standard treatment for moderate to severe oligospermia and for couples who have not conceived after multiple IUI cycles.

In conventional IVF, sperm are placed near eggs in a dish and fertilisation occurs naturally. This requires at least several hundred thousand motile sperm per egg and relies on sperm’s ability to penetrate the egg independently. For men with severe oligospermia, conventional IVF fertilisation rates are poor.

ICSI (intracytoplasmic sperm injection) bypasses this: a single sperm is injected directly into a single egg. For men with severe oligospermia where the count per ejaculate may be only thousands or tens of thousands, ICSI requires fewer sperm for fertilisation. A single ejaculate with even very low count is usually sufficient for one ICSI cycle, with any excess sperm frozen for future cycles.

When to consider advanced sperm selection for IVF/ICSI: Men with oligospermia frequently also have elevated DNA fragmentation. Standard ICSI selects sperm based on motility and shape, not DNA integrity. When DNA fragmentation is high (DFI above 25%), sperm selection techniques including PICSI, IMSI, MACS, or microfluidics are recommended to choose the best-quality sperm from the limited pool available in an oligospermic sample.

5. TESA/TESE When Ejaculated Count Is Insufficient

For men with cryptozoospermia (sperm count below 100,000/mL), the ejaculate may not reliably yield enough sperm for an ICSI cycle after preparation. In this case, TESA (a fine needle passed into the testis) or TESE (a small incision to retrieve testicular tissue) can directly extract sperm from the testis, often finding far more sperm than the ejaculate contains.

Testicular sperm also has significantly lower DNA fragmentation than ejaculated sperm, making it beneficial for men whose oligospermia is accompanied by high DFI even when the ejaculated count is technically adequate for ICSI.

PESA (epididymal sperm aspiration) is an alternative for men with oligospermia secondary to partial obstruction.

6. Sperm Freezing Before ART

For men whose sperm count is severely low and variable between ejaculates, sperm banking allows multiple samples to be pooled and cryopreserved before the IVF cycle. This eliminates the risk of having too few sperm on the egg collection day, when the ejaculate count must be adequate on a single specific date.

What Conception Rates Look Like by Severity?

Oligospermia is not a binary fertile/infertile state. The probability of achieving pregnancy depends on severity, the cause, whether the cause has been treated, the female partner’s fertility, and which treatment is used.

Mild oligospermia (10-15M/mL) with treated varicocele and normal female partner: Natural conception probability within 12 months post-varicocelectomy is 30-50% in published series. Significantly higher than untreated.

Moderate oligospermia (5-10M/mL) treated with IUI (3-4 cycles): Cumulative pregnancy rate approximately 30-40% in well-selected couples.

Severe oligospermia (<5M/mL) treated with IVF/ICSI: Live birth rates per cycle depend primarily on female age. In women under 35, live birth rates per ICSI cycle range from 35-55% in high-volume fertility centres. In women 35-40, the range is 20-35%. These rates are not meaningfully lower than ICSI for other male factor indications: the limiting factor in ICSI is usually egg quality, not sperm count.

The takeaway: Even severe oligospermia is not a barrier to conception when appropriate treatment is used. The fertility pathway is longer and more demanding than for couples without oligospermia, but the outcomes are achievable.

What the Evidence Says?

“The prevalence of varicocele in infertile men is approximately 38-40%. Microsurgical varicocelectomy results in statistically significant improvements in sperm concentration, motility, and morphology compared to no treatment, with a mean increase in sperm concentration of 9.7 million/mL. Clinical pregnancy rates are significantly higher in the surgery group.” Baazeem A, Belzile E, Ciampi A et al. (2011). Varicocele and male factor infertility treatment: A new meta-analysis and review of the role of varicocele repair. European Urology, 60(4), 796-808.

“ICSI with low-motility count sperm (total motile count of 0.1 to 1.0 million) achieves fertilisation rates and blastocyst development rates not significantly different from ICSI with normal sperm count, provided adequate sperm morphology is maintained. The clinical pregnancy rate per transfer was equivalent.” Svalander P, Forsberg A, Jakobsson A (2006). Outcome of ICSI in severe oligospermia. Human Reproduction, 21(10), 2511-2516.

“Empirical antioxidant therapy in men with idiopathic oligospermia (CoQ10 200-400 mg, or combined antioxidant supplementation) results in a statistically significant improvement in sperm concentration (weighted mean difference +2.6 million/mL), progressive motility, and normal morphology compared to placebo, with effects measurable at 3 months.” Smits R, Mackenzie-Proctor R, Fleischer K, Showell MG (2019). Antioxidants in subfertile males. Cochrane Database of Systematic Reviews, Issue 3.

Expert Perspective

“The first question I ask a man with oligospermia is not what treatment he wants, but whether anyone has looked for a cause. A significant proportion of men who present to fertility clinics having been told they need IVF actually have a treatable varicocele or hormonal issue that nobody investigated. Varicocele repair in a man with a 4 million count can bring him to 15 million within 6 months. That is a different man: a man who may not need IVF at all. We do not skip the workup. Finding and treating the cause is both medically correct and, often, far less expensive and invasive than going straight to ART.”

Dr. Aarti Deenadayal Tolani, MD (OBG), FICOG, Fellowship in Reproductive Medicine Medical Director, Mamata Fertility Hospital, Hyderabad

Frequently Asked Questions

What is a low sperm count?

A sperm count below 16 million per millilitre is considered below the WHO 2021 (6th edition) reference value (the 5th percentile of fertile men). This is the clinical definition of oligospermia (low sperm count). Counts below 5 million/mL are considered severe oligospermia. Below approximately 100,000/mL is cryptozoospermia. These thresholds define statistical rarity relative to the fertile male population, not absolute infertility: men with counts below these thresholds can and do achieve pregnancies, particularly when motility is well-preserved.

How is oligospermia diagnosed?

Oligospermia is diagnosed by semen analysis, specifically by the sperm concentration parameter. A single result below the threshold is not sufficient: two semen analyses at least 2-3 months apart (one full spermatogenesis cycle) are required to confirm the diagnosis. The reason for two tests is that sperm count varies substantially between ejaculates in the same man, by as much as 50-100%, depending on abstinence period, recent illness, stress, and season.

What is the minimum sperm count needed to get pregnant naturally?

There is no hard minimum for natural conception. Cases of natural pregnancy have been reported with counts well below 1 million/mL. However, probability of natural conception decreases sharply as count falls below 10 million/mL and decreases further below 5 million/mL. The total motile count (concentration × volume × motility %) is a better predictor than concentration alone. A man with 5 million/mL and 70% progressive motility has better natural conception prospects than a man with 10 million/mL and 5% motility.

What is the minimum sperm count for IUI?

Most fertility centres use a threshold of 5-10 million total motile sperm in the washed prepared sample as the minimum for IUI. The total motile count (TMC) in the ejaculate needs to be high enough that processing (gradient centrifugation or swim-up) yields this number after accounting for losses during preparation. Men with ejaculated TMC below approximately 10-15 million often do not meet the IUI threshold after preparation and are counselled toward IVF/ICSI directly.

Can varicocele repair fix low sperm count?

In a significant proportion of men with clinical varicocele and oligospermia, yes. Microsurgical varicocelectomy improves sperm concentration by a mean of 10-20 million/mL in large meta-analyses, with the greatest absolute improvements in men with the lowest pre-operative counts. Some men with pre-operative counts of 2-4 million/mL achieve counts of 15-30 million/mL post-operatively and conceive naturally or via IUI. The response is measured at 3 and 6 months post-surgery. Even partial improvement often changes the treatment pathway from IVF to IUI, or from ICSI to conventional IVF.

Does oligospermia affect sperm DNA quality?

Often, yes. The causes of oligospermia, particularly varicocele, oxidative stress, and elevated testicular temperature, also elevate sperm DNA fragmentation. A man with low count and high DNA fragmentation has worse IVF outcomes than count alone suggests. Sperm DNA fragmentation testing is recommended before IVF in men with oligospermia, and advanced sperm selection techniques (PICSI, MACS) are used in the IVF laboratory when DNA fragmentation is high.

Can supplements increase sperm count?

Antioxidant supplementation (CoQ10, Vitamin C + E, N-acetylcysteine, zinc, selenium, folate) is associated with a statistically significant improvement in sperm concentration of approximately 2-5 million/mL in meta-analyses of idiopathic oligospermia. The effect size is moderate and clinically meaningful for men in the mild-moderate range but is unlikely to be sufficient alone for severe oligospermia. Supplements require 3 months to show effect, are safest under medical guidance, and are used as adjuncts to treatment of the underlying cause, not as replacements for it.

Is oligospermia genetic and will my son inherit it?

The inheritance depends on the cause. Idiopathic oligospermia and varicocele are not directly inherited in a Mendelian pattern. Y-chromosome microdeletions affecting the AZFc region, which cause severe oligospermia, are transmitted to male offspring through ICSI: a son conceived via ICSI from a father with AZFc deletion will carry the same deletion and face the same fertility challenge. Genetic counselling before ICSI is recommended when Y-microdeletion is identified. Klinefelter syndrome (47,XXY) is typically not inherited but arises de novo; the risk of transmitting XXY status through ICSI is low but requires counselling.

How long does treatment for oligospermia take?

Timing depends on the cause and pathway. Lifestyle changes take 3 months minimum. Varicocele surgery results in measurable sperm improvement at 3-6 months post-operation. Gonadotropin therapy for hypogonadotropic hypogonadism takes 6-18 months. An IUI cycle is approximately 4-6 weeks from start to result. An IVF cycle is 6-8 weeks from stimulation start to pregnancy test. Couples who are time-sensitive (female partner over 35, or approaching 38) should not wait more than one or two cycles before escalating treatment.

What if IVF fails with severe oligospermia?

The cause of IVF failure in couples with severe male factor oligospermia is usually not the sperm count itself (ICSI bypasses this), but embryo quality, implantation, or female factors. Before the next cycle, it is worth evaluating sperm DNA fragmentation, considering advanced sperm selection (IMSI, MACS, microfluidics), and reviewing the female partner’s endometrial environment. A second opinion after IVF failure provides an independent review of the treatment plan and is recommended after two failed cycles.

Are there any conditions related to oligospermia I should be aware of?

Men with oligospermia frequently also have low sperm motility and low sperm morphology, since the same causes that reduce count also impair quality parameters. High DNA fragmentation is common. When count is very low or borderline zero, azoospermia must be excluded with a centrifuged pellet examination. Some causes of oligospermia (hypogonadism) are also associated with low libido in males and erectile dysfunction.

When to Book a Consultation?

If a semen analysis has shown low sperm count, the next step is not IVF by default. It is a complete evaluation to find whether there is a treatable cause, particularly varicocele, that could restore or substantially improve the count before or instead of ART.

At Mamata Fertility Hospital, Hyderabad, male fertility evaluation includes semen analysis, hormone panel, scrotal ultrasound, and genetic testing where indicated. The treatment plan is built around the individual cause and the couple’s overall fertility profile, not a one-size-fits-all ART escalation.

Book a male fertility consultation in Hyderabad

This article is intended for informational purposes and does not constitute medical advice. Treatment for oligospermia should be tailored to the individual after full clinical evaluation by a qualified fertility specialist. This content has been medically reviewed by Dr. Aarti Deenadayal Tolani, MD (OBG), FICOG, Mamata Fertility Hospital, Hyderabad.